Company: AFRM
Filing Date: 2025-10-24
Form Type: DEF 14A
Source: 0001628280-25-046264
Chunk: 48

Company: Affirm Holdings, Inc.
Filing Date: 2025-10-24
Form: DEF 14A
Chunk 48
---
602,824 |
| Michael Linford                                          |     |                | 900,000 |     |                                          | 9,156,418 |   |                                           | 18,567,309 |     |                   | 35,907 |     |       | 28,659,634 |
| Libor Michalek                                           |     |                | 900,000 |     |                                          | 8,891,058 |   |                                           | 18,512,498 |     |                   | 35,907 |     |       | 28,339,463 |
| Katherine Adkins                                         |     |                | 720,000 |     |                                          | 7,511,715 |   |                                           |  6,274,659 |     |                   | 27,322 |     |       | 14,533,696 |

(1) Represents a lump sum cash payment in an amount equal to the sum of (i) the named executive officer’s annual base salary in effect as of June 30, 2025, multiplied by 150% for our CEO and 100% for our other named executive officers, plus (ii) the named executive officer’s target annual cash incentive plan opportunity, if any, in effect as of June 30, 2025 as if a change in control occurred on June 30, 2025.

(2) The value of accelerated vesting of unvested RSU awards is based upon the closing price of our Class A common stock on June 30, 2025 of $69.14 per share multiplied by the number of unvested RSUs.

(3) The value of accelerated vesting of unvested in-the-money options is based on the difference between the closing price of our Class A common stock on June 30, 2025 of $69.14 per share and the exercise price per option multiplied by the number of unvested options. The value of accelerated vesting of unvested out-of-the money options is assumed to be $0.

(4) Represents the monthly premiums for continued health benefits as of June 30, 2025 for 18 months for our CEO and 12 months for each of our other named executive officers.

| Qualifying Termination Outside of a Change in Control Period |     |                |         |     |                                   |     |   |                                    |     |   |                   |        |     |       |         |
| Name                                                         |     | Cash